Merck Tbk (JK:MERK) — Market Cap & Net Worth
Market Cap & Net Worth: Merck Tbk (MERK)
Merck Tbk (JK:MERK) has a market capitalization of $100.28 Million (Rp1.71 Trillion) as of September 24, 2026. Listed on the JK stock exchange, this Indonesia-based company holds position #19286 globally and #338 in its home market, demonstrating a -2.30% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Merck Tbk's stock price Rp3820.00 by its total outstanding shares 448000000 (448.00 Million). Also see Merck Tbk asset portfolio for a full breakdown of the balance sheet.
Merck Tbk Market Cap History: 2015 to 2026
Merck Tbk's market capitalization history from 2015 to 2026. Data shows growth from $80.26 Million to $100.28 Million (1.99% CAGR). Also see MERK cash flow conversion for how efficiently the company converts equity into cash flow.
Index Memberships
Merck Tbk is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Jakarta Stock Exchange Composite Index
JKSE
|
$495.15 Billion | 0.02% | #329 of 864 |
Weight: Merck Tbk's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Merck Tbk Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Merck Tbk's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check current stock price of Merck Tbk for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.00x
Merck Tbk's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
Merck Tbk's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $80.26 Million | $983.45 Billion | $142.55 Billion | 0.00x | 0.00x |
| 2016 | $110.55 Million | $1.03 Trillion | $153.84 Billion | 0.00x | 0.00x |
| 2017 | $105.32 Million | $1.16 Trillion | $144.68 Billion | 0.00x | 0.00x |
| 2018 | $85.56 Million | $611.96 Billion | $1.16 Trillion | 0.00x | 0.00x |
| 2019 | $56.71 Million | $744.63 Billion | $78.26 Billion | 0.00x | 0.00x |
| 2020 | $67.78 Million | $655.85 Billion | $71.90 Billion | 0.00x | 0.00x |
| 2021 | $79.04 Million | $1.06 Trillion | $131.66 Billion | 0.00x | 0.00x |
| 2022 | $107.86 Million | $1.12 Trillion | $179.84 Billion | 0.00x | 0.00x |
| 2023 | $101.37 Million | $961.43 Billion | $178.24 Billion | 0.00x | 0.00x |
| 2024 | $94.50 Million | $1.04 Trillion | $153.46 Billion | 0.00x | 0.00x |
Competitor Companies of MERK by Market Capitalization
Companies near Merck Tbk in the global market cap rankings as of September 24, 2026. Review Merck Tbk (MERK) tangible equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Merck Tbk by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #524 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #586 globally with a market cap of $46.44 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #638 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #651 globally with a market cap of $42.68 Billion USD ( CN¥291.65 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #524 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #586 | GALDERMA GROUP AG | NYSE:GALDY | $46.44 Billion | $39.83 |
| #638 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.50 |
| #651 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $42.68 Billion | CN¥45.72 |
Merck Tbk Historical Marketcap From 2015 to 2026
Between 2015 and today, Merck Tbk's market cap moved from $80.26 Million to $ 100.28 Million, with a yearly change of 1.99%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rp100.28 Million | +14.03% |
| 2025 | Rp87.94 Million | -6.94% |
| 2024 | Rp94.50 Million | -6.77% |
| 2023 | Rp101.37 Million | -6.01% |
| 2022 | Rp107.86 Million | +36.45% |
| 2021 | Rp79.04 Million | +16.61% |
| 2020 | Rp67.78 Million | +19.53% |
| 2019 | Rp56.71 Million | -33.72% |
| 2018 | Rp85.56 Million | -18.76% |
| 2017 | Rp105.32 Million | -4.73% |
| 2016 | Rp110.55 Million | +37.74% |
| 2015 | Rp80.26 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 23rd, 2026 the market cap of Merck Tbk was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $100.28 Million USD |
| MoneyControl | $100.28 Million USD |
| MarketWatch | $100.28 Million USD |
| marketcap.company | $100.28 Million USD |
| Reuters | $100.28 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Merck Tbk
PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally. The company operates through Biopharma, Consumer Health, and Others segments. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in research an… Read more